SLC2A3 and B-cell chronic lymphocytic leukemia: Further, although no change in the expression of GLUT3 and PFKFB3 was detected between the CLL cells in patients with indolent or progressive disease, we found increased levels of HK2 in cells from patients with CLL progression (Suppl.